Ethnicity Inclisiran

3 source-based articles maintained by the HealthRX.com Editorial Team.

3articles

2topic areas covered

Jan 28, 2025latest review

Ethnicity Inclisiran library

Showing 3 of 3 clinical reviews.

Dosing & MonitoringJan 28, 2025

Leqvio (Inclisiran) Dosing in Black and African Ancestry Patients: What the Evidence Actually Shows

A clinician-focused review of inclisiran pharmacokinetics, subgroup efficacy data, pharmacogenomic considerations, and dose-adjustment guidance for Black and African ancestry patients receiving Leqvio for LDL-C lowering.

Dosing & MonitoringMay 27, 2026

Leqvio (Inclisiran) East Asian Dose Adjustments: Pharmacogenomics, Trial Data, and Clinical Guidance

Does Leqvio (inclisiran) require dose adjustments for East Asian patients? We review ORION trial subgroup data, siRNA pharmacology, CYP polymorphism relevance, and BMI-based considerations.

Clinical ReviewsMay 27, 2026

Leqvio (Inclisiran) in East Asian Patients: Documented Efficacy Gaps and Pharmacogenomic Considerations

Evidence review of inclisiran efficacy in East Asian populations, covering ORION trial subgroup data, PCSK9 genetic variants, dosing, and pharmacogenomic differences that may affect LDL-C lowering.